During the past decade, Yale University School of Medicine ; Pulmonary & Critical Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yale University School of Medicine ; Pulmonary & Critical Care" are "Duchenne Muscular Dystrophy" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Relapsing Multiple Sclerorsis" (1 trials). Many other conditions were trialed in "Yale University School of Medicine ; Pulmonary & Critical Care" in a lesser frequency.

Most popular intervention types in "Yale University School of Medicine ; Pulmonary & Critical Care" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antihistamine" (1 trials), "Lumbar Puncture" (1 trials), "Methyloprednisolone" (1 trials), "Ocrelizumab" (1 trials) and "Placebo for RO7239361" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale University School of Medicine ; Pulmonary & Critical Care" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yale University School of Medicine ; Pulmonary & Critical Care". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yale University School of Medicine ; Pulmonary & Critical Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale University School of Medicine ; Pulmonary & Critical Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".